Will to Cure ALD Launches $1.2M Research Portfolio Across Six Centers

Will to Cure ALD today announced the launch of its initial research portfolio, committing more than $1.2 million to high-priority Adrenoleukodystrophy (ALD) research projects across all six ALD Connect Centers of Excellence.

This is one of the largest coordinated philanthropic investment ever directed specifically toward ALD research.

The funding supports 14 projects spanning cerebral ALD prevention, AMN prevention, biomarker discovery, and next-generation therapeutic development, a meaningful step forward for a disease that has historically received limited research investment.